Dodick DW, Goadsby PJ, Schwedt TJ, Lipton RB, et al. Ubrogepant for the treatment of migraine attacks during the prodrome: a phase 3, multicentre, randomised, double-blind, placebo-controlled, crossover trial in the USA. Lancet 2023 Nov 15:S0140-6736(23)01683-5. doi: 10.1016/S0140-6736(23)01683.
PMID: 37979595